The chapters in this book can be broadly categorized into four major themes: Global regulatory processes (Chapters 2, 4, 5, and 7): This section provides a regulatory perspective and reviews existing global regulatory processes . It also proposes new and innovative ways for regulatory review of excipients, which, if adopted, should promote innovation. This section also provides a status update on the global compendial harmonization, which should eliminate non–value-added testing that manufacturers and users of excipients currently have to perform. Preclinical testing and development and development of new and coprocessed excipients (Chapters 3, 6, 9, and 20): This section describes the type of preclinical testing that is required in support of the development and registration of new excipients and presents a case study for successful development of a novel excipient. Lastly, Chapter 20 looks to the future and identifies excipients needed for innovative biotechnologically derived dosage forms.  (read more) or download here